112 related articles for article (PubMed ID: 8216559)
21. Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.
Yukawa T; Kroegel C; Evans P; Fukuda T; Chung KF; Barnes PJ
Immunology; 1989 Sep; 68(1):140-3. PubMed ID: 2807369
[TBL] [Abstract][Full Text] [Related]
22. Modulation of eosinophil recruitment in the rat by the platelet-activating factor (PAF) antagonist, BN 52021, the somatostatin analog, BIM 23014, and by cyclosporin A.
Etienne A; Soulard C; Thonier F; Braquet P
Prostaglandins; 1989 Mar; 37(3):345-57. PubMed ID: 2748916
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone.
Hartnell A; Kay AB; Wardlaw AJ
Immunology; 1992 Dec; 77(4):488-93. PubMed ID: 1493920
[TBL] [Abstract][Full Text] [Related]
24. Luminol-chemiluminescence in free peritoneal cells in hemorrhagic shock in rats treated with PAF-receptor-antagonist BN 52021.
Debek W; Gruca P; Chyczewski L; Gruca A
Rocz Akad Med Bialymst; 1995; 40(1):129-37. PubMed ID: 8528982
[TBL] [Abstract][Full Text] [Related]
25. Platelet-activating-factor-induced augmentation of production of eosinophil-lineage cells in hematopoietic precursor cells obtained from human umbilical cord blood.
Saito H; Koshio T; Yanagihara Y; Akiyama K; Shida T
Int Arch Allergy Immunol; 1993; 102(4):375-82. PubMed ID: 8241800
[TBL] [Abstract][Full Text] [Related]
26. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines.
Okada S; Kita H; George TJ; Gleich GJ; Leiferman KM
Am J Respir Cell Mol Biol; 1997 Apr; 16(4):455-63. PubMed ID: 9115757
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of degranulation from human eosinophils by platelet-activating factor.
Kroegel C; Yukawa T; Dent G; Venge P; Chung KF; Barnes PJ
J Immunol; 1989 May; 142(10):3518-26. PubMed ID: 2541198
[TBL] [Abstract][Full Text] [Related]
28. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
McColl SR; Krump E; Naccache PH; Poubelle PE; Braquet P; Braquet M; Borgeat P
J Immunol; 1991 Feb; 146(4):1204-11. PubMed ID: 1846895
[TBL] [Abstract][Full Text] [Related]
29. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG.
Bartemes KR; McKinney S; Gleich GJ; Kita H
J Immunol; 1999 Mar; 162(5):2982-9. PubMed ID: 10072549
[TBL] [Abstract][Full Text] [Related]
30. Platelet-activating factor potentiates interleukin-1/epidermal cell-derived thymocyte-activating factor release by guinea-pig keratinocytes stimulated with lipopolysaccharide.
Pignol B; Lonchampt MO; Chabrier PE; Mencia-Huerta JM; Braquet P
J Lipid Mediat; 1990; 2 Suppl():S83-91. PubMed ID: 2133287
[TBL] [Abstract][Full Text] [Related]
31. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein.
Silva AR; de Assis EF; Caiado LF; Marathe GK; Bozza MT; McIntyre TM; Zimmerman GA; Prescott SM; Bozza PT; Castro-Faria-Neto HC
J Immunol; 2002 Apr; 168(8):4112-20. PubMed ID: 11937571
[TBL] [Abstract][Full Text] [Related]
32. PAF antagonism as an approach to the treatment of airway hyperreactivity.
Meade CJ; Heuer H
Am Rev Respir Dis; 1991 Mar; 143(3 Pt 2):S79-82. PubMed ID: 2003696
[TBL] [Abstract][Full Text] [Related]
33. Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.
e Silva PM; Martins MA; Faria Neto HC; Cordeiro RS; Vargaftig BB
J Pharmacol Exp Ther; 1991 Jun; 257(3):1039-44. PubMed ID: 2046020
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of the expression of eosinophil IgE receptor (Fc epsilon R2) and its function by platelet-activating factor.
Walsh GM; Moqbel R; Nagakura T; Iikura Y; Kay AB
J Lipid Mediat; 1990; 2 Suppl():S177-86. PubMed ID: 1966815
[TBL] [Abstract][Full Text] [Related]
35. Increased sensitivity of the chemoattractant-induced chemiluminescence in eosinophils isolated from atopic individuals.
Koenderman L; Bruijnzeel PL
Immunology; 1989 Aug; 67(4):534-6. PubMed ID: 2767711
[TBL] [Abstract][Full Text] [Related]
36. The effect of transendothelial migration on eosinophil function.
Yamamoto H; Sedgwick JB; Vrtis RF; Busse WW
Am J Respir Cell Mol Biol; 2000 Sep; 23(3):379-88. PubMed ID: 10970830
[TBL] [Abstract][Full Text] [Related]
37. IL-1 is a potent inducer of eosinophil accumulation in rat skin. Inhibition of response by a platelet-activating factor antagonist and an anti-human IL-8 antibody.
Sanz MJ; Weg VB; Bolanowski MA; Nourshargh S
J Immunol; 1995 Feb; 154(3):1364-73. PubMed ID: 7822803
[TBL] [Abstract][Full Text] [Related]
38. Selective eosinophil leukocyte recruitment by transendothelial migration and not by leukocyte-endothelial cell adhesion.
Morland CM; Wilson SJ; Holgate ST; Roche WR
Am J Respir Cell Mol Biol; 1992 May; 6(5):557-66. PubMed ID: 1316135
[TBL] [Abstract][Full Text] [Related]
39. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
Ukena D; Dent G; Chanez P; Barnes PJ; Sybrecht GW
Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
[TBL] [Abstract][Full Text] [Related]
40. Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells.
Pignol B; Hénane S; Sorlin B; Rola-Pleszczynski M; Mencia-Huerta JM; Braquet P
J Immunol; 1990 Aug; 145(3):980-4. PubMed ID: 2373865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
